DRKS00010675尚未招募不适用
Expression of programmed cell death-1 (PD-1) and its ligand PD-L1 and PD-L2 as well as the enzyme indolamin 2,3-dioxygenase (IDO) in primary lymphomas of the skin
niversitätsklinik FreiburgDermatologie und Venerologie0 个研究点目标入组 40 人开始时间: 2016年6月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Programmed cell death ligand 1 expression and clinical correlation in epithelial ovarian carcinoma patientsEpithelial Ovarian Carcinoma patientsOvary,Carcinoma,Prognosis,PDL1TCTR20161115004Siriraj Research Development Fund92
Unknown
不适用
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control StudyLichen PlanusNCT04892381Cairo University60
Unknown
不适用
PD-L1 Expression in Advanced OsteosarcomaProgressionSurvivalNCT03582527Peking University People's Hospital50
Unknown
不适用
The Predictive Role of Programmed Death Ligand 1 (PD-L1) and Neutrophil to Lymphocyte Ratio (NLR) in Non-Small Cell Lung Cancer (NSCLC)To Define an Easy and Feasible Panel Which May be Routinely Applied to Select Patients for Immunotherapy Avoiding More Complex and Expensive MethodsNCT03816657Fondazione Ricerca Traslazionale93
尚未招募
不适用
correlation between blood levels of immune co-inhibitory molecules disease severity and treatment response in alopecia areata patientsCTRI/2021/03/032196Post Graduate Institute of Medical Education and Research Chandigarh